Core Viewpoint - China Feihe has launched the country's first comprehensive structural database for human milk oligosaccharides (HMOs), marking a significant advancement in the analysis and application of breast milk components, which are crucial for infant health [1][2]. Group 1: Database and Research Initiatives - The HMO database addresses long-standing challenges in the detection and analysis of HMOs, providing a solid foundation for precise breast milk analysis in China [1]. - The project is part of the "14th Five-Year Plan" national key research initiative, focusing on the development of new infant formula manufacturing technologies based on Chinese breast milk research [1][2]. - Feihe has collaborated with five top universities and research institutions, forming a "national team" for breast milk research, and has invested nearly 100 million yuan in additional funding [1][2]. Group 2: Research Methodology and Findings - The project employs an innovative mother-child cohort study approach, allowing for more accurate assessments of the long-term health effects of breastfeeding compared to traditional cross-sectional studies [2]. - Feihe has achieved significant breakthroughs in systematically analyzing key nutritional components of Chinese breast milk, including proteins, fatty acids, and HMOs, establishing a proprietary knowledge system for breast milk research [3]. - The project is recognized as a key national research initiative, reflecting the government's support for enterprises to lead major scientific projects [3]. Group 3: Technological Innovations - Feihe has introduced advanced methodologies, such as organoid models and AI algorithms, to enhance the understanding of breast milk components and their interactions [4]. - The company has developed the first autonomous breast milk intelligence engine, capable of analyzing vast amounts of cohort data to study the dynamics of breast milk components [4].
飞鹤发布国内首个应用型母乳低聚糖全谱系结构数据库